PEG FILTERO 6MG

Peg Filtero 6mg Injection contains Pegfilgrastim as its active ingredient. This medication falls under the category of granulocyte colony-stimulating factors and has been approved by the FDA to reduce the likelihood of febrile neutropenia (the occurrence of fever or infection due to low white blood cell count) and to shorten the duration of neutropenia (a low white blood cell count) in patients undergoing chemotherapy that suppresses bone marrow. Additionally, it is indicated to enhance survival rates in individuals subjected to radiation therapy, which can inflict severe and life-threatening harm to bone marrow. The drug functions by acting on blood-forming cells, promoting cell multiplication and activating cell functions.

Pegfilgrastim is a protein produced through biotechnological methods using E. coli bacteria. It is part of the cytokine protein family and closely resembles a natural protein (granulocyte-colony stimulating factor) that your body produces. White blood cells (WBC) play a crucial role in helping your body fend off infections. These cells are particularly vulnerable to the effects of chemotherapy, which can lead to a reduction in their numbers. A decrease in WBC can leave your body with insufficient cells to fight off bacteria, increasing your risk of infection.

Before beginning treatment with this Injection, inform your physician if you have or have ever had liver disease, fever or infection, kidney issues, heart problems, or a family history of kidney diseases. Avoid using this Injection if you are allergic to pegfilgrastim, filgrastim, or any other components of this Injection. Immediately report any symptoms such as pain in the left upper abdomen, shoulder pain, or respiratory issues to your doctor. The most frequently reported side effects of Peg Filtero 6mg injection include pain in the bones, arms, and legs.